Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2020-03, Vol.99 (3), p.649-651
Hauptverfasser:	Rassidakis, George Z., Stromberg, Olga, Xagoraris, Ioanna, Jatta, Kenbugul, Sonnevi, Kristina
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Cell Transdifferentiation Head and Neck Neoplasms - diagnostic imaging Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - genetics Head and Neck Neoplasms - pathology Hematology Histiocytic Sarcoma - diagnostic imaging Histiocytic Sarcoma - drug therapy Histiocytic Sarcoma - genetics Histiocytic Sarcoma - pathology Humans Imidazoles - administration & dosage Letter to the Editor Leukemia, Lymphocytic, Chronic, B-Cell - diagnostic imaging Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - genetics Leukemia, Lymphocytic, Chronic, B-Cell - pathology Male Medicine Medicine & Public Health Oncology Oximes - administration & dosage Proto-Oncogene Proteins B-raf - genetics Proto-Oncogene Proteins p21(ras) - genetics Pyridones - administration & dosage Pyrimidinones - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!